 Krishna Mallela
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Utrophin | 6 | 2017 | 7 | 3.100 |
Why?
| | Microfilament Proteins | 6 | 2017 | 134 | 2.870 |
Why?
| | Dystrophin | 6 | 2015 | 30 | 2.830 |
Why?
| | Calcium-Binding Proteins | 6 | 2017 | 217 | 2.470 |
Why?
| | Protein Unfolding | 6 | 2018 | 34 | 2.070 |
Why?
| | Actins | 6 | 2017 | 404 | 1.970 |
Why?
| | Interferon-alpha | 4 | 2018 | 191 | 1.940 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 94 | 1.750 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 228 | 1.630 |
Why?
| | Protein Folding | 15 | 2010 | 250 | 1.580 |
Why?
| | Protein Aggregates | 5 | 2018 | 70 | 1.410 |
Why?
| | Protein Binding | 14 | 2023 | 1975 | 1.400 |
Why?
| | Preservatives, Pharmaceutical | 3 | 2014 | 24 | 1.310 |
Why?
| | Cytochromes c | 6 | 2011 | 64 | 1.290 |
Why?
| | Antibodies, Monoclonal | 3 | 2018 | 1284 | 1.200 |
Why?
| | Protein Stability | 8 | 2021 | 164 | 1.070 |
Why?
| | Benzyl Alcohol | 3 | 2014 | 10 | 1.020 |
Why?
| | Protein Conformation | 8 | 2018 | 848 | 0.990 |
Why?
| | Models, Molecular | 15 | 2018 | 1435 | 0.990 |
Why?
| | Immunoglobulin G | 2 | 2018 | 788 | 0.970 |
Why?
| | Protein Structure, Secondary | 14 | 2019 | 338 | 0.940 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2022 | 14 | 0.890 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 823 | 0.870 |
Why?
| | Mutation, Missense | 3 | 2014 | 300 | 0.860 |
Why?
| | Methionine | 2 | 2019 | 145 | 0.830 |
Why?
| | Anti-Infective Agents | 2 | 2014 | 227 | 0.770 |
Why?
| | Amyloid beta-Peptides | 1 | 2022 | 200 | 0.740 |
Why?
| | Thermodynamics | 11 | 2017 | 392 | 0.740 |
Why?
| | Asparagine | 1 | 2019 | 30 | 0.720 |
Why?
| | Drug Compounding | 2 | 2023 | 90 | 0.680 |
Why?
| | Horses | 9 | 2012 | 106 | 0.650 |
Why?
| | Protein Subunits | 2 | 2012 | 211 | 0.650 |
Why?
| | Excipients | 1 | 2018 | 50 | 0.650 |
Why?
| | Oxidants | 1 | 2018 | 122 | 0.630 |
Why?
| | Polysorbates | 1 | 2017 | 35 | 0.620 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2017 | 35 | 0.610 |
Why?
| | Lymphokines | 1 | 2017 | 122 | 0.610 |
Why?
| | Ketones | 1 | 2017 | 45 | 0.610 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2017 | 69 | 0.600 |
Why?
| | Aldehydes | 1 | 2017 | 154 | 0.580 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 940 | 0.560 |
Why?
| | Molecular Chaperones | 1 | 2017 | 174 | 0.560 |
Why?
| | Recombinant Proteins | 5 | 2021 | 1308 | 0.550 |
Why?
| | Protein Denaturation | 5 | 2011 | 73 | 0.540 |
Why?
| | Light | 1 | 2018 | 342 | 0.540 |
Why?
| | Cresols | 2 | 2014 | 4 | 0.520 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2071 | 0.490 |
Why?
| | Binding Sites | 4 | 2023 | 1224 | 0.480 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 276 | 0.470 |
Why?
| | Antiviral Agents | 1 | 2018 | 654 | 0.440 |
Why?
| | Protein Domains | 2 | 2023 | 212 | 0.400 |
Why?
| | Biophysical Phenomena | 4 | 2015 | 64 | 0.380 |
Why?
| | Cytochrome c Group | 5 | 2004 | 37 | 0.380 |
Why?
| | Muscular Dystrophies | 1 | 2010 | 36 | 0.370 |
Why?
| | Mutation | 5 | 2022 | 3457 | 0.370 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2871 | 0.350 |
Why?
| | Kinetics | 10 | 2014 | 1624 | 0.320 |
Why?
| | Surface-Active Agents | 2 | 2020 | 81 | 0.320 |
Why?
| | Drug Stability | 2 | 2018 | 153 | 0.320 |
Why?
| | Hydrogen | 6 | 2004 | 65 | 0.310 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 4 | 2018 | 240 | 0.300 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 2851 | 0.300 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2017 | 138 | 0.270 |
Why?
| | Circular Dichroism | 3 | 2017 | 139 | 0.270 |
Why?
| | Humans | 15 | 2023 | 118972 | 0.250 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2015 | 372 | 0.240 |
Why?
| | Amino Acids | 2 | 2019 | 464 | 0.230 |
Why?
| | Receptors, Virus | 1 | 2023 | 78 | 0.230 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2023 | 101 | 0.220 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2022 | 33 | 0.220 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2022 | 18 | 0.220 |
Why?
| | Benzoquinones | 1 | 2022 | 44 | 0.220 |
Why?
| | Mutant Proteins | 2 | 2014 | 100 | 0.220 |
Why?
| | NAD | 1 | 2022 | 67 | 0.210 |
Why?
| | Fluorescent Dyes | 4 | 2012 | 316 | 0.210 |
Why?
| | Deuterium Exchange Measurement | 3 | 2007 | 30 | 0.210 |
Why?
| | Immune Evasion | 1 | 2022 | 48 | 0.210 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 51 | 0.210 |
Why?
| | Transition Temperature | 1 | 2021 | 28 | 0.210 |
Why?
| | Dependovirus | 1 | 2021 | 52 | 0.190 |
Why?
| | Cell Proliferation | 2 | 2018 | 2275 | 0.190 |
Why?
| | Protein Multimerization | 2 | 2012 | 161 | 0.190 |
Why?
| | Animals | 12 | 2022 | 33381 | 0.180 |
Why?
| | Genetic Vectors | 1 | 2021 | 302 | 0.180 |
Why?
| | Escherichia coli | 2 | 2014 | 758 | 0.170 |
Why?
| | Proteins | 4 | 2008 | 938 | 0.170 |
Why?
| | HEK293 Cells | 1 | 2021 | 625 | 0.170 |
Why?
| | tert-Butylhydroperoxide | 1 | 2018 | 10 | 0.170 |
Why?
| | Amidines | 1 | 2018 | 16 | 0.170 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2017 | 508 | 0.170 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 363 | 0.170 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2018 | 49 | 0.160 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 17 | 0.160 |
Why?
| | Temperature | 2 | 2012 | 622 | 0.160 |
Why?
| | Proteolysis | 1 | 2018 | 146 | 0.160 |
Why?
| | Receptors, Fc | 1 | 2018 | 48 | 0.160 |
Why?
| | Models, Biological | 4 | 2008 | 1715 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 667 | 0.150 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 46 | 0.150 |
Why?
| | Hydrolysis | 1 | 2017 | 176 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 7 | 2007 | 536 | 0.150 |
Why?
| | Molecular Weight | 1 | 2017 | 343 | 0.150 |
Why?
| | Solubility | 1 | 2017 | 235 | 0.150 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 177 | 0.150 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 178 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 305 | 0.150 |
Why?
| | Adenosine Triphosphatases | 1 | 2017 | 158 | 0.140 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 24 | 0.140 |
Why?
| | Nanoparticles | 1 | 2020 | 325 | 0.140 |
Why?
| | Carbocyanines | 3 | 2001 | 30 | 0.140 |
Why?
| | Mass Spectrometry | 1 | 2018 | 681 | 0.130 |
Why?
| | Ethylene Glycols | 1 | 2014 | 15 | 0.130 |
Why?
| | Phenol | 1 | 2014 | 17 | 0.120 |
Why?
| | SUMO-1 Protein | 1 | 2014 | 21 | 0.120 |
Why?
| | Bacterial Load | 1 | 2014 | 61 | 0.120 |
Why?
| | Chromatography, Gel | 1 | 2014 | 133 | 0.120 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 61 | 0.120 |
Why?
| | Biochemistry | 2 | 2008 | 40 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2062 | 0.120 |
Why?
| | Area Under Curve | 1 | 2014 | 296 | 0.110 |
Why?
| | Pyrenes | 1 | 2012 | 6 | 0.110 |
Why?
| | Cloning, Molecular | 1 | 2014 | 546 | 0.110 |
Why?
| | Crystallography, X-Ray | 1 | 2014 | 422 | 0.110 |
Why?
| | Solutions | 1 | 2012 | 156 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1094 | 0.100 |
Why?
| | Cysteine | 1 | 2012 | 184 | 0.100 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2014 | 344 | 0.100 |
Why?
| | Caveolae | 1 | 2001 | 16 | 0.100 |
Why?
| | Sequence Alignment | 1 | 2012 | 336 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 653 | 0.100 |
Why?
| | Cattle | 1 | 2014 | 978 | 0.100 |
Why?
| | Membrane Lipids | 1 | 2001 | 88 | 0.090 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 140 | 0.090 |
Why?
| | Solvents | 1 | 2010 | 118 | 0.090 |
Why?
| | Anesthetics, Local | 1 | 2010 | 85 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 2 | 2005 | 173 | 0.090 |
Why?
| | Multiprotein Complexes | 1 | 2010 | 149 | 0.090 |
Why?
| | Lipid Bilayers | 1 | 1999 | 100 | 0.080 |
Why?
| | Micrococcal Nuclease | 1 | 2008 | 19 | 0.080 |
Why?
| | Cell Line | 1 | 2014 | 2707 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3174 | 0.080 |
Why?
| | Phosphatidylcholines | 1 | 1997 | 133 | 0.070 |
Why?
| | Liposomes | 1 | 1997 | 151 | 0.070 |
Why?
| | Methyl Ethers | 1 | 2005 | 8 | 0.070 |
Why?
| | Receptors, GABA | 1 | 2005 | 9 | 0.070 |
Why?
| | Models, Chemical | 4 | 2008 | 274 | 0.070 |
Why?
| | Halothane | 1 | 2005 | 5 | 0.070 |
Why?
| | Anesthetics, Inhalation | 1 | 2005 | 14 | 0.070 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 191 | 0.060 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 154 | 0.050 |
Why?
| | Fluorescence Polarization | 2 | 2001 | 35 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2021 | 267 | 0.040 |
Why?
| | Particle Size | 1 | 2020 | 345 | 0.040 |
Why?
| | Egg Proteins | 1 | 2007 | 19 | 0.040 |
Why?
| | Muramidase | 1 | 2007 | 72 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 200 | 0.030 |
Why?
| | Probability | 1 | 2005 | 305 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 6412 | 0.030 |
Why?
| | Biophysics | 1 | 2002 | 73 | 0.030 |
Why?
| | Tritium | 1 | 2001 | 70 | 0.030 |
Why?
| | Hydrogen Bonding | 1 | 2001 | 146 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2001 | 146 | 0.020 |
Why?
| | Rotation | 1 | 2001 | 121 | 0.020 |
Why?
| | History, 20th Century | 1 | 2001 | 281 | 0.020 |
Why?
| | Surface Properties | 1 | 2001 | 397 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2001 | 490 | 0.020 |
Why?
| | Sucrose | 1 | 1999 | 104 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1999 | 86 | 0.020 |
Why?
| | Guanidine | 1 | 2008 | 18 | 0.020 |
Why?
| | Molecular Structure | 1 | 1999 | 459 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2007 | 75 | 0.020 |
Why?
| | Amides | 1 | 2007 | 86 | 0.020 |
Why?
| | Protons | 1 | 2006 | 79 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2008 | 556 | 0.020 |
Why?
| | Titrimetry | 1 | 2003 | 9 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 2003 | 88 | 0.010 |
Why?
| | Proteomics | 1 | 2008 | 876 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 2874 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2445 | 0.010 |
Why?
|
|
Mallela's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|